Understanding resistance to EGFR inhibitors—impact on future treatment strategies

医学 表皮生长因子受体抑制剂 癌症研究 血管生成 癌症 吉非替尼 表皮生长因子受体 后天抵抗 生物信息学 机制(生物学) 靶向治疗 内科学 抗药性 生物 微生物学 哲学 认识论
作者
Deric L. Wheeler,Emily Dunn,Paul M. Harari
出处
期刊:Nature Reviews Clinical Oncology [Nature Portfolio]
卷期号:7 (9): 493-507 被引量:694
标识
DOI:10.1038/nrclinonc.2010.97
摘要

EGFR is one of the most studied targets in oncology, and several inhibitors have shown promising results in selected patient populations. However, intrinsic and acquired resistance to these targeted therapies is increasingly recognized. The authors of this Review describe the successful translation of EGFR inhibitors to the clinic, and highlight the mechanisms of resistance to these agents that limit their long-term efficacy. Understanding these processes will allow researchers to develop therapies that overcome resistance and ultimately lead to more successful outcomes. EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis. Following ligand binding, EGFR stimulates downstream cell signaling cascades that influence cell proliferation, apoptosis, migration, survival and complex processes, including angiogenesis and tumorigenesis. EGFR has been strongly implicated in the biology of human epithelial malignancies, with therapeutic applications in cancers of the colon, head and neck, lung, and pancreas. Accordingly, targeting EGFR has been intensely pursued, with the development of a series of promising molecular inhibitors for use in clinical oncology. As is common in cancer therapy, challenges with respect to treatment resistance emerge over time. This situation is certainly true of EGFR inhibitor therapies, where intrinsic and acquired resistance is now well recognized. In this Review, we provide a brief overview regarding the biology of EGFR, preclinical and clinical development of EGFR inhibitors, and molecular mechanisms that underlie the development of treatment resistance. A greater understanding of the mechanisms that lead to EGFR resistance may provide valuable insights to help design new strategies that will enhance the impact of this promising class of inhibitors for the treatment of cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SLL发布了新的文献求助10
1秒前
3277125325发布了新的文献求助10
1秒前
2秒前
2秒前
NexusExplorer的应助被饺子采纳,获得10
2秒前
搜集达人的应助被111采纳,获得10
3秒前
领导范儿的应助被hamster666采纳,获得10
3秒前
forever完成签到,获得积分10
3秒前
小马甲的应助被漆漆采纳,获得10
3秒前
小晴天的应助被整点儿薯条采纳,获得20
3秒前
八爪鱼完成签到,获得积分10
4秒前
9391发布了新的文献求助10
4秒前
研友_8Y26PL发布了新的文献求助10
4秒前
5秒前
5秒前
7秒前
Sapphire完成签到,获得积分10
8秒前
万柏祺完成签到,获得积分10
9秒前
9秒前
智慧完成签到,获得积分10
9秒前
第四周期发布了新的文献求助10
9秒前
醉卧星河发布了新的文献求助10
9秒前
dlsq完成签到,获得积分10
10秒前
10秒前
molihuakai的应助被myz采纳,获得10
10秒前
圈圈儿完成签到 ,获得积分10
10秒前
土豆饼完成签到,获得积分20
11秒前
12秒前
9391完成签到,获得积分10
13秒前
AlexMoser发布了新的文献求助10
13秒前
Peterpk发布了新的文献求助10
13秒前
13秒前
14秒前
饺子发布了新的文献求助10
14秒前
完美世界的应助被张张采纳,获得10
14秒前
流氓煎蛋完成签到 ,获得积分10
15秒前
达不溜发布了新的文献求助10
16秒前
无花果的应助被riddle采纳,获得10
16秒前
企鹅公路完成签到,获得积分10
17秒前
科研通AI2S的应助被漂亮冰薇采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187918
求助须知:如何正确求助?哪些是违规求助? 9575850
关于积分的说明 21843829
捐赠科研通 7785760
什么是DOI,文献DOI怎么找? 3435128
关于科研通互助平台的介绍 2559501
邀请新用户注册赠送积分活动 2482027